HAMBURG, Germany, May 18, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Roche (SWX:RO) (SWX:ROG) (OTCQX:RHHBY) today decided to voluntarily terminate the first proof-of-concept study ...
SAN DIEGO, April 3, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the first patient has been randomized for its Phase 2 clinical study to evaluate the efficacy, ...
BALTIMORE, April 19, 2013 -- Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results